Jardiance vs. Glimepiride

See how Jardiance and Glimepiride compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Jardiance is an SGLT2 inhibitor with proven heart and kidney benefits, while glimepiride is a sulfonylurea that only lowers blood sugar.

  • Glimepiride carries a higher risk of hypoglycemia on its own and costs far less per month than Jardiance.

  • Jardiance is approved for children 10 and older, heart failure, and chronic kidney disease, while glimepiride is approved only for adults with type 2 diabetes.

Jardiance vs. Glimepiride Drug Summary

Jardiance

Jardiance (empagliflozin) is an SGLT2 inhibitor that lowers blood sugar by causing the kidneys to remove excess glucose through urine. It is taken as a once-daily oral tablet and is also approved to reduce cardiovascular death, heart failure hospitalization, and chronic kidney disease progression.

Glimepiride

Glimepiride is a sulfonylurea that lowers blood sugar by stimulating the pancreas to release more insulin. It is taken as a once-daily oral tablet alongside diet and exercise, and is used only to treat type 2 diabetes in adults.

Jardiance vs. Glimepiride Side Effects

Jardiance

Most common
Hypoglycemia (up to 41.3%)
Volume depletion related reactions (up to 11.4%)
Urinary tract infection (up to 9.3%)
Female genital mycotic infection (up to 5.4%)

Glimepiride

Most common
Hypoglycemia (>5%)
Dizziness (>5%)
Asthenia (>5%)
Headache (>5%)

Jardiance vs. Glimepiride Dosage

Jardiance

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 25 mg once daily If needed
Dose changes 1 increase As tolerated

Glimepiride

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily At the start
Maximum dose 8 mg once daily If needed
Dose changes 3 increases As tolerated

Jardiance vs. Glimepiride Indications

Jardiance

Jardiance treats type 2 diabetes and also protects the heart and kidneys in people with related conditions. It is approved for adults and children 10 and older with type 2 diabetes, plus adults with heart failure or chronic kidney disease regardless of diabetes status.

  • Type 2 diabetes blood sugar control (ages 10+)

  • Reduces cardiovascular death in adults with type 2 diabetes and heart disease

  • Reduces hospitalization and death in heart failure, any ejection fraction

  • Slows progression of chronic kidney disease

Glimepiride

Glimepiride treats type 2 diabetes by helping the body release more of its own insulin. It is approved only for blood sugar control in adults, used alongside diet and exercise, with no additional approved use.

  • Type 2 diabetes blood sugar control in adults

  • Used alongside diet and exercise

  • Not approved for heart, kidney, or cardiovascular protection

  • Not approved for children

Jardiance vs. Glimepiride Pros and Cons

Jardiance

Jardiance offers proven heart and kidney protection beyond blood sugar control, making it a strong choice for patients with cardiovascular or renal risk. It costs significantly more than older generic options and carries some class-specific risks like ketoacidosis and genital infections.

Pros

  • Reduces risk of cardiovascular death and heart failure hospitalization

  • Slows chronic kidney disease progression

  • Approved for children 10 and older with type 2 diabetes

  • Lower hypoglycemia risk when used alone

Cons

  • Costs roughly $350 to $620 per month without insurance, before savings programs

  • Carries a risk of diabetic ketoacidosis, even with normal blood sugar

  • Can cause genital yeast infections and urinary tract infections

  • Not recommended for patients with significant kidney impairment

Glimepiride

Glimepiride is an inexpensive, well-established option for lowering blood sugar in type 2 diabetes. It lacks cardiovascular or kidney protective effects and carries a higher risk of hypoglycemia than newer drug classes.

Pros

  • Costs roughly $10 to $20 per month without insurance, before savings programs

  • Decades of clinical use with a well-understood safety profile

  • No risk of genital infections or diabetic ketoacidosis

  • Simple oral titration schedule

Cons

  • No proven cardiovascular or kidney benefit

  • Higher risk of hypoglycemia, especially in older adults

  • Associated with possible increased cardiovascular mortality (UGDP study)

  • Risk of hemolytic anemia in patients with G6PD deficiency

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.